Lu L - Search Results

1

Hepatic-associated vascular morphological assessment to predict overt hepatic encephalopathy before TIPS: a multicenter study.

Chen X, Huang M, Yu X, Chen J, Xu C, Jiang Y, Li Y, Zhao Y, Duan C, Luo Y, Zhang J, Lv W, Li Q, Luo J, Dong D, An T, Lu L, Fu S. Chen X, et al. Among authors: lu l. Hepatol Int. 2024 Aug;18(4):1238-1248. doi: 10.1007/s12072-024-10686-2. Epub 2024 Jun 4. Hepatol Int. 2024. PMID: 38833138 Free PMC article.

2

Sorafenib continuation after first disease progression could reduce disease flares and provide survival benefits in patients with hepatocellular carcinoma: a pilot retrospective study.

Fu SR, Zhang YQ, Li Y, Hu BS, He X, Huang JW, Zhan MX, Lu LG, Li JP. Fu SR, et al. Asian Pac J Cancer Prev. 2014;15(7):3151-6. doi: 10.7314/apjcp.2014.15.7.3151. Asian Pac J Cancer Prev. 2014. PMID: 24815462 Free article.

3

The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.

Zheng YB, Zhan MX, Zhao W, Liu B, Huang JW, He X, Fu SR, Zhao Y, Li Y, Hu BS, Lu LG. Zheng YB, et al. Med Oncol. 2014 Oct;31(10):209. doi: 10.1007/s12032-014-0209-z. Epub 2014 Sep 3. Med Oncol. 2014. PMID: 25182707

4

Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma.

Chen K, Zhan MX, Hu BS, Li Y, He X, Fu SR, Xin YJ, Lu LG. Chen K, et al. Oncol Lett. 2018 Jan;15(1):315-323. doi: 10.3892/ol.2017.7291. Epub 2017 Oct 30. Oncol Lett. 2018. PMID: 29285194 Free PMC article.

5

CT-based radiomics to predict development of macrovascular invasion in hepatocellular carcinoma: A multicenter study.

Wei JW, Fu SR, Zhang J, Gu DS, Li XQ, Chen XD, Zhang ST, He XF, Yan JF, Lu LG, Tian J. Wei JW, et al. Hepatobiliary Pancreat Dis Int. 2022 Aug;21(4):325-333. doi: 10.1016/j.hbpd.2021.09.011. Epub 2021 Oct 3. Hepatobiliary Pancreat Dis Int. 2022. PMID: 34674948

6

Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.

Lu J, Guo JH, Ji JS, Li YL, Lv WF, Zhu HD, Sun JH, Ren WX, Zhang FJ, Wang WD, Shao HB, Cao GS, Li HL, Gao K, Yang P, Yin GW, Zhu GY, Wu FZ, Wang WJ, Lu D, Chen SQ, Min J, Zhao Y, Li R, Lu LG, Lau WY, Teng GJ. Lu J, et al. Int J Surg. 2023 May 1;109(5):1188-1198. doi: 10.1097/JS9.0000000000000295. Int J Surg. 2023. PMID: 37038986 Free PMC article. Clinical Trial.

7

3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study.

Chen X, Wang T, Ji Z, Luo J, Lv W, Wang H, Zhao Y, Duan C, Yu X, Li Q, Zhang J, Chen J, Zhang X, Huang M, Zhou S, Lu L, Huang M, Fu S. Chen X, et al. Among authors: lu l. Hepatol Int. 2023 Dec;17(6):1545-1556. doi: 10.1007/s12072-023-10570-5. Epub 2023 Aug 2. Hepatol Int. 2023. PMID: 37531069 Free PMC article.

8

Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study.

Liu Y, Fu S, Yu X, Zhang J, Zhu S, Yang Y, Huang J, Luo H, Tang K, Zheng Y, Zhao Y, Chen X, Zhan M, He X, Li Q, Duan C, Chen Y, Lu L. Liu Y, et al. Among authors: lu l. BMC Cancer. 2023 Oct 12;23(1):969. doi: 10.1186/s12885-023-11357-5. BMC Cancer. 2023. PMID: 37828461 Free PMC article.

9

A modified model for predicting mortality after transjugular intrahepatic portosystemic shunt: A multicentre study.

Zhao Y, Yang Y, Lv W, Zhu S, Chen X, Wang T, Huang M, An T, Duan C, Yu X, Li Q, Chen J, Luo J, Zhou S, Lu L, Huang M, Fu S. Zhao Y, et al. Among authors: lu l. Liver Int. 2024 Feb;44(2):472-482. doi: 10.1111/liv.15790. Epub 2023 Nov 27. Liver Int. 2024. PMID: 38010919

10

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma.

Peng K, Zhang X, Li Z, Wang Y, Sun HW, Zhao W, Pan J, Zhang XY, Wu X, Yu X, Wu C, Weng Y, Lin X, Liu D, Zhan M, Xu J, Zheng L, Zhang Y, Lu L. Peng K, et al. Among authors: lu l. Front Immunol. 2024 Dec 2;15:1493735. doi: 10.3389/fimmu.2024.1493735. eCollection 2024. Front Immunol. 2024. PMID: 39687612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,029 results

Search Page

Filters